Skip to main content
. Author manuscript; available in PMC: 2009 Oct 16.
Published in final edited form as: Nature. 2009 Apr 16;458(7240):859–864. doi: 10.1038/nature07885

Figure 2.

Figure 2

Experimental testing of anti-bZIP designs. A) Peptide array results for the most specific design identified for each human bZIP family. Columns show experiments using the indicated protein to probe an array. For the Specificity panel (left), designs in solution were used to probe human bZIPs and designs on the surface. In the Relative Stability panel (right), human bZIP targets were used to probe an array containing the cognate design of each target and 33 human bZIPs. Data are plotted as -log(F/Fmax), with F the fluorescence signal on the array, such that the strongest interaction has a value of zero. Values of -log(F/Fmax) above 1.0 were set to 1.0. Thick red circles – design•target; thin red circles – design interactions with siblings in the target family; grey squares – interactions with other human bZIPs; black squares – design•design. Designs are named using the family of their target. B) Solution testing of anti-SMAF complexes assayed using circular dichroism. In each panel, anti-SMAF alone is shown with dashed lines, the partner being tested with a solid line, the numerical average of these two signals with open circles (◦) and the mixture of the two peptides with closed circles (•). (B, C) Anti-SMAF interacts with target MafG (Tm ~ 38 °C). (D) Anti-SMAF interacts, at most, very weakly with cJun, the closest competitor according to microarray data. (E) There is no evidence for anti-SMAF interacting with MafB, a sequence closely related to the target. CD spectra in (B) were collected at 25 °C. Anti-SMAF unfolds with Tm ~12 °C. Similar data for other complexes are included in Supplemenatary Figures 38.